Home » Topics » BioWorld Science

BioWorld Science
RSS

T Cell Sciences: Q3 1997 highlights

Nov. 13, 1997

Regeneron: Q3 1997 highlights

Nov. 13, 1997

New 5-LO inhibitors from Meiji Milk

Nov. 13, 1997

ACAT inhibitors described by Sankyo in patent literature

Nov. 13, 1997

Suntory's penems are active against MRSA

Nov. 13, 1997

Sankyo synthesizes azole aromatase inhibitors

Nov. 13, 1997

TNFR:Fc evaluated in patients with heart failure

Nov. 13, 1997

Shaman: Q3 1997 highlights

Nov. 13, 1997

Lerisetron: a potent, selective, long-acting and orally effective 5-HT3 antagonist

Nov. 12, 1997

New guidelines for treating hypertension

Nov. 12, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...